ECD Auto Design Adds Black Dog Traders Branded Classic Toyota FJ SUVs to Product Lineup
June 04, 2024 08:30 ET
|
E.C.D. Automotive Design
KISSIMMEE, Fla., June 04, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq:ECDA) (“ECD” or the “Company”), the world’s largest Land Rover and Jaguar restoration company known for its...
FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors
June 03, 2024 16:02 ET
|
FibroGen, Inc.
The safety and efficacy of FG-3165 will be evaluated in a Phase 1 trial in select solid tumorsPlan to begin enrollment in 2H 2024 SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- FibroGen,...
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
June 03, 2024 08:14 ET
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
May 22, 2024 08:05 ET
|
MaxCyte, Inc
ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
May 22, 2024 06:30 ET
|
G1 Therapeutics
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
May 21, 2024 08:00 ET
|
Alvotech
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and...
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession License
May 21, 2024 07:10 ET
|
Carbon Streaming Corporation
Carbon Streaming Announces Update On The Status Of The Rimba Raya Verra Account And Concession License
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
May 16, 2024 20:02 ET
|
Erasca, Inc.
Pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 are potent, oral inhibitors with potential best-in-class profiles in RASm solid tumors Pipeline prioritization and workforce...
Carbon Streaming Announces Further Update on Rimba Raya Project
May 15, 2024 21:30 ET
|
Carbon Streaming Corporation
Carbon Streaming Announces Further Update On Rimba Raya Project
Irish Continental Group plc (ICG) subsidiary Irish Ferries signs space charter agreement with P&O Ferries
May 15, 2024 10:57 ET
|
Irish Continental Group Plc
ICG is pleased to announce that its subsidiary Irish Ferries has signed a space charter agreement with P&O Ferries on the Dover – Calais route. This agreement will encompass both freight and...